Wide Ranks

MYNZ

Mainz Biomed N.V.

0.2560

Top Statistics
Market Cap 16 M Forward PE -0.5278 Revenue Growth 4.60 %
Current Ratio 0.24 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.6410 Enterprise / Revenue 15.09 Price To Sales Trailing12 Months 17.87
Profitability
Profit Margins 0.00 % Operating Margins -1883.22 %
Balance Sheet
Total Cash 977764 Total Cash Per Share 0.0380 Total Debt 8 M
Total Debt To Equity Current Ratio 0.24 Book Value Per Share -0.1620
All Measures
Short Ratio 76.00 % Message Board Id finmb_1679642292 Shares Short Prior Month 1 M
Return On Equity -43.34 City Mainz Uuid 74995154-4535-3bd7-9d98-8548f3c030bf
Previous Close 0.2250 First Trade Date Epoch Utc 1 B Book Value -0.1620
Beta 0.0760 Total Debt 8 M Volume 4 M
Fifty Two Week Low 0.1850 Total Cash Per Share 0.0380 Total Revenue 917203
Shares Short Previous Month Date 1 B Max Age 86400 Recommendation Mean 3.00
Sand P52 Week Change 0.3133 Operating Margins -1883.22 % Net Income To Common -22506846
Short Percent Of Float 0.0589 Implied Shares Outstanding 64 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 3 M Average Volume10days 3 M
Total Cash 977764 Next Fiscal Year End 1 B Revenue Per Share 0.0460
Held Percent Insiders 0.2022 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.2250 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.2552 Open 0.2340
Free Cashflow -12579566 Dividend Yield 0.00 % Return On Assets -0.9924
Time Zone Short Name EST Trailing Eps -1.11 Day Low 0.2316
Address1 Robert Koch Strasse 50 Shares Outstanding 64 M Price Hint 4
Target High Price 0.0000 Website https://mainzbiomed.com 52 Week Change -0.7754
Average Volume 3 M Forward Eps -0.7400 Recommendation Key hold
Quick Ratio 13.10 % Is_sp_500 False Regular Market Day High 0.2639
Profit Margins 0.00 % Fifty Two Week High 1.79 Day High 0.2639
Shares Short 3 M Regular Market Open 0.2340 Industry Key diagnostics-research
Earnings Growth 0.00 % Enterprise To Revenue 15.09 Revenue Growth 4.60 %
Shares Percent Shares Out 0.0557 Operating Cashflow -19305464 Currency USD
Time Zone Full Name America/New_York Market Cap 16 M Is_nasdaq_100 False
Zip 55129 Quote Type EQUITY Industry Diagnostics & Research
Long Name Mainz Biomed N.V. Regular Market Day Low 0.2316 Held Percent Institutions 0.0088
Current Price 0.2560 Enterprise To Ebitda -0.6410 Financial Currency USD
Current Ratio 0.24 Gross Margins 58.98 % Industry Disp Diagnostics & Research
Country Germany Float Shares 22 M Two Hundred Day Average 0.5577
Enterprise Value 13 M Price To Sales Trailing12 Months 17.87 Forward PE -0.5278
Regular Market Volume 4 M Ebitda -21590572 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Mainz Biomed N.

V.

develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States.

The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test.

It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer.

It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product.

The company was founded in 2008 and is based in Mainz, Germany.